FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas

BACKGROUND: Molecular profiling of gliomas is vital to ensure diagnostic accuracy, inform prognosis, and identify clinical trial options for primary and recurrent tumors. This study aimed to determine the accuracy of reporting the whole arm 1p19q codeletion status from the FoundationOne platform. ME...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurooncol Adv
Main Authors: Sharaf, Radwa, Pavlick, Dean C, Frampton, Garrett M, Cooper, Maureen, Jenkins, Jacqueline, Danziger, Natalie, Haberberger, James, Alexander, Brian M, Cloughesy, Timothy, Yong, William H, Liau, Linda M, Nghiemphu, Phioanh L, Ji, Matthew, Lai, Albert, Ramkissoon, Shakti H, Albacker, Lee A
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2021
Assuntos:
Basic and Translational Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7986056/
https://ncbi.nlm.nih.gov/pubmed/33778493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab017
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados